Literature DB >> 104017

Bone scintigraphy in renal osteodystrophy.

P de Graaf, I M Schicht, E K Pauwels, J te Velde, J de Graeff.   

Abstract

Bone scintigraphy with Tc-99m HEDP was performed in 30 patients on maintenance hemodialysis, and the results of quantitative analysis were compared with those of a normal group. To permit this comparison, elevated background activity due to the absence of renal radiotracer excretion was reduced by hemodialysis to levels found in the normals. Histologic proof of renal osteodystrophy had been obtained in all patients. The incidence of radiographic abnormalities was 46%, whereas abnormal scans were found in 25 patients (83%); skeletal lesions were also more pronounced and detected earlier. However, even when the scans appeared normal, the quantitative analysis showed increased skeletal activity in all patients. The total skeletal activity proved to be a good index of the severity of renal osteodystrophy and appeared dependent on both osteomalacia and hyperparathyroidism. These findings show that bone scintigraphy is a sensitive method to detect skeletal involvement in renal osteodystrophy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104017

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  99mTc-MIBI accumulation in the parathyroid autograft in a patient with recurrent hyperparathyroidism.

Authors:  H Ohta; T Komibuchi; M Nishimura; K Nishimura; Y Nagao; H Watanabe; S Fujikawa; S Nakaishi; S Oki
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

2.  Observations on computerized quantitative bone scintigraphy in renal osteodystrophy.

Authors:  P de Graaf; E K Pauwels; P H Vos; I M Schicht; J te Velde; J de Graeff
Journal:  Eur J Nucl Med       Date:  1984

3.  Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.

Authors:  P de Graaf; J te Velde; E K Pauwels; I M Schicht; K Kleiverda; J de Graeff
Journal:  Eur J Nucl Med       Date:  1982

4.  A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.

Authors:  T Kida; S Narita
Journal:  Eur J Nucl Med       Date:  1987

5.  Differential diagnosis between secondary hyperparathyroidism and aluminum intoxication in uremic patients: usefulness of 99mTc-pyrophosphate bone scintigraphy.

Authors:  P Kinnaert; I Van Hooff; A Schoutens; P Bergmann; M Fuss; M Dratwa; A Vienne; J L Pasteels; J van Geertruyden; J L Vanherweghem
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

6.  Bone scanning in the child and young adult. Part I.

Authors:  I P Murray
Journal:  Skeletal Radiol       Date:  1980-02       Impact factor: 2.199

7.  Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease.

Authors:  C Alberts; J B van der Schoot; E Busemann-Sokole
Journal:  Eur J Nucl Med       Date:  1981

Review 8.  Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.

Authors:  F A de Jonge; E K Pauwels; N A Hamdy
Journal:  Eur J Nucl Med       Date:  1991

9.  Deconvolution analysis of 99mTc-methylene diphosphonate kinetics in metabolic bone disease.

Authors:  J Knop; E Kröger; P Stritzke; C Schneider; H P Kruse
Journal:  Eur J Nucl Med       Date:  1981-02

10.  Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.

Authors:  C Velentzas; D G Oreopoulos; A Pierratos; H E Meema; S Rabinovich; H Meindok; H Husdan; T M Murray; R Ogilvie; A Katirtzoglou
Journal:  Can Med Assoc J       Date:  1981-03-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.